Mark Munsell, M.S.

Senior Statistical Analyst

Department of Biostatistics

The University of Texas M. D. Anderson Cancer Center

 

 

Publications:

 

  • Montemurro S, Rondón G, Ueno NT, Munsell M, Gajewski JL, Champlin RE.  Factors affecting progression-free survival in hormone dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor-cell transplantation: role of maintenance endocrine therapy.  Bone Marrow Tranplant.  In press.

  •  

  • Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkins lymphoma.  Annals of Oncology 2002; 13:450-459.

  •  

  • Abushullaih S, Saad ED, Munsell M, Hoff PM.  Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience.  Cancer Invest 2002; 20(1):3010.

  •  

  • Konopleva M, Tsao T, Ruvulo P, Stiouf I, Estrov Z, Leysath CE, Zhao S, Harris D, Chang, S, Jackson CE, Munsell M, Suh N, Gribble G, Honda T, May W S, Sporn MB, Andreeff M.  Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.  Blood 2002; 99(1):236-235.

  •  

  • Rodriguez J, Munsell M, Yazji S, Hagemeister FB, Younes A, Andersson B, Giralt S, Gajewski J, de Lima M, Couriel D, Romaguera J, Cabanillas FF, Champlin RE, Khouri IF.  Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001; 19(17):3766-3770.

  •  

  • Kreider KA, Stratmann RG, Milano M, Agostini FG, Munsell M.  Reducing children's injection pain: lidocaine patches versus topical benzocaine gel. Pediatr Dent 2001; 23(1):19-23.

  •  

  • Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, Grimm EA. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.  Clin Cancer Res 2000; 6(12):4768-4775.

  •  

  • Clark D, Munsell M, Emery J.  A mathematical model to predict the need for neodymium:YAG capsulotomy based on posterior capsule opacification rate. J Cataract Refract Surg 1998; 24(12):1621-1625.

  •  

  • Clark D, Emery J, Munsell M. Inhibition of posterior capsule opacification with an immunotoxin specific for lens epithelial cells: 24-month clinical results. J Cataract Refract Surg 1998; 24(12):1614-1620.

  •  

  • Lewis R, Podbielski J, Munsell M, Katz S, Van Buren C., Kerman R, Kahan BD.  Stability of renal allograft glomerular filtration rate in the cyclosporine era: 2-year follow-up.  Transplant Proc 1994; 26(5):2619-2261.

  •  

  • Lewis RM, Podbielski J, Munsell M, Katz S, Van Buren C, Kerman R, Kahan, B.  Optimization and long-term evaluation of renal function in sandimmune-treated renal allograft recipients.  Transplant Proc 1993; 25(4 Suppl 3):10-12.

  •  

  • Lewis R, Podbielski J, Sprayberry S, Munsell M, Katz S, Rubin M, Kimball P, Van Buren CT, Kerman R, Kahan B.  Stability of renal allograft glomerular filtration rate (GFR) associated with long-term use of cyclosporine A.  Transplantation 1993; 55(5):1014-1017.

  •  

  • Rodriquez MA, Fuller LM, Zimmerman SO, Allen PK, Brown BW, Munsell M, Hagemeister FB, McLaughlin P, Velasquez WS, Swan Jr. F, Cabanillas FF.  Hodgkin’s Disease: study of treatment intensities and incidences of second malignancies.  Ann Oncol 1993; 4(2):125-131.

  •  

  • Rutledge FN, Mitchell MF, Munsell M, Bass S, McGuffee V, Atkinson EN.  Youth as a prognostic factor in squamous cell carcinoma of the cervix: a matched analysis. Gynecol Oncol 1992; 44(2):123-130.

  •  

  • Ng EH, Pollock RE, Munsell M, Atkinson EN, Romsdahl MM.  Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging.  Ann Surg 1992; 215(1):68-77.

  •  

  • Rutledge FN, Mitchell MF, Munsell M, Atkinson EN, Bass S, McGuffee V, Silva E.  Prognostic indicators for invasive carcinoma of the vulva.  Gynecol Oncol 1991; 42(3):239-244.